Pavan Patel

Stock Analyst at B of A Securities

(0.27)
# 4,402
Out of 5,173 analysts
1
Total ratings
n/a
Success rate
-9.78%
Average return

Stocks Rated by Pavan Patel

Supernus Pharmaceuticals
Oct 29, 2025
Initiates: Buy
Price Target: $65
Current: $49.25
Upside: +31.98%